Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for ���������������������������������������������:kn39��� returned no results
Showing 751 to 765 of 815 results for ���������������������������������������������:know���

  1. NICE draft guidance does not recommend siponimod for treating secondary progressive multiple sclerosis

    NICE has today (25 June 2020) issued draft guidance for public consultation which does not recommend siponimod (also called Mayzent and made by Novartis) for treating secondary progressive multiple sclerosis (MS).

  2. NICE draft guidance recommends new treatment for chronic heart failure

    Up to 150,000 people in England with a type of chronic heart failure are set to benefit from a new treatment following its approval by NICE.

  3. NICE and PHE publish comprehensive draft guideline to tackle the health burden of smoking

    Healthcare staff should give clear and up-to-date information on e-cigarettes to people who are interested in using them to stop smoking, according to draft NICE guideline recommendations out for consultation today. NICE worked with Public Health England to develop this guideline

  4. NICE announces Dr Samantha Roberts as new Chief Executive

    NICE Chairman, Sharmila Nebhrajani, today announced Dr Samantha Roberts as incoming Chief Executive.

  5. New NICE guideline will help doctors recognise and refer people with suspected neurological conditions

    NICE’s new guideline is the first to offer comprehensive information on neurological conditions to help non-specialist healthcare professionals to identify people who should be referred for specialist assessment and care.

  6. New quality standards to help care homes manage medicines safely and prevent falls in older people

    Two new quality standards on managing medicines in care homes and preventing falls will help to improve the quality of care for older people.

  7. New recommended drinking guidelines welcomed by NICE

    NICE has welcomed proposed new guidelines on alcohol which aim to limit the health risks that result from drinking.

  8. New treatment to increase the chances of a successful kidney transplant recommended by NICE

    A new treatment that increases the chance of a successful kidney transplant has been recommended by NICE in final draft guidance today (16 June 2022).

  9. NICE approves new treatment for stroke prevention

    Patients with atrial fibrillation can now be offered rivaroxaban (Xarelto), as an alternative to warfarin, in order to reduce their risk of stroke and blood clots, says NICE.

  10. NICE calls for further research into the treatment of chronic lipoedema

    NICE has today issued interventional procedures guidance on the use of liposuction for the treatment of chronic lipoedema.

  11. NICE calls on care homes to prioritise the oral health of residents

    Care home residents should be helped to brush their teeth twice a day, says NICE

  12. NICE chief executive and chairman thank non-executive director for his service as he announces resignation

    Professor Martin Cowie stands down from the NICE board following his appointment to a role at Astra Zeneca

  13. NICE draft guidance does not recommend pembrolizumab plus chemotherapy for triple negative breast cancer

    Draft guidance published today (8 March 2022) by NICE for public consultation does not recommend pembrolizumab plus chemotherapy for treating triple negative breast cancer that has spread to other parts of the body.

  14. Minimum pricing for alcohol 'will protect young people'

    Setting a minimum price per unit of alcohol, as recommended by NICE, will protect young people from the dangers of excessive drinking, according to a new report.

  15. Four innovative tests for diagnosing UTIs could help in the fight against antimicrobial resistance

    Innovative tests with the potential to help people with a urinary tract infection (UTI) receive the correct course of antibiotics more quickly could soon be considered for use in the NHS.